# Sprint 12 — Paid evidence and packaging decision report

Date: 2026-07-13. Status: **INSTRUMENTATION PASS / COMMERCIAL EVIDENCE PENDING**.

REVORY now records workspace-scoped, idempotent evidence for audit conversion, first-value time, useful findings, confirmed recovered value, second read, audit-to-subscription conversion, support minutes, retention intent, false-positive disputes, plan interest and weekly-decision usefulness.

Each offer receives its own deterministic decision. Fewer than five independent observations returns `DELAY`. Sufficient evidence can return `RETAIN` or `REPACKAGE`; the engine never automatically cuts price and never borrows evidence from another offer.

The Growth history screen asks whether the exact state-fingerprinted weekly decision was useful. The decision itself remains minimum-sample guarded, single-currency and explicitly a review priority rather than a performance verdict. Rate and supported value are shown together so the largest cohort is not presented without denominator context.

The weekly decision passed local usefulness validation as a decision-support mechanism: it is deterministic for the same state fingerprint, requires a minimum sample, suppresses mixed-currency value, shows both absolute impact and finding rate, asks one bounded management question and records feedback against the exact state that produced it. This proves that the UI cannot manufacture a confident recommendation from thin or incompatible evidence; it does **not** prove that customers will act on or value the decision. That commercial proof remains customer-shaped evidence owned by the founder after the local sprints.

## Verification

- `npm run qa:sprint-12`: PASS.
- No real-customer event was fabricated or seeded.
- Current packaging outcome without customer data: Audit DELAY, Starter DELAY, Growth DELAY, Pro DELAY.

The user explicitly owns real-data/customer validation after the sprints. Sprint 12 implementation is complete, but its roadmap commercial exit is not.
